Treatment of severe steroid refractory ulcerative colitis
Open Access
- 1 January 2008
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (36), 5508-5511
- https://doi.org/10.3748/wjg.14.5508
Abstract
Although systemic steroids are highly efficacious in ulcerative colitis (UC), failure to respond to steroids still poses an important challenge to the surgeon and physician alike. Even if the life time risk of a fulminant UC flare is only 20%, this condition is potentially life threatening and should be managed in hospital. If patients fail 3 to 5 d of intravenous corticosteroids and optimal supportive care, they should be considered for any of three options: intravenous cyclosporine (2 mg/kg for 7 d, and serum level controlled), infliximab (5 mg/kg IV, 0-2-6 wk) or total colectomy. The choice between these three options is a medical-surgical decision based on clinical signs, radiological and endoscopic findings and blood analysis (CRP, serum albumin). Between 65 and 85% of patients will initially respond to cyclosporine and avoid colectomy on the short term. Over 5 years only 50% of initial responders avoid colectomy and outcomes are better in patients naive to azathioprine (bridging strategy). The data on infliximab as a medical rescue in fulminant colitis are more limited although the efficacy of this anti tumor necrosis factor (TNF) monoclonal antibody has been demonstrated in a controlled trial. Controlled data on the comparative efficacy of cyclosporine and infliximab are not available at this moment. Both drugs are immunosuppressants and are used in combination with steroids and azathioprine, which infers a risk of serious, even fatal, opportunistic infections. Therefore, patients not responding to these agents within 5-7 d should be considered for colectomy and responders should be closely monitored for infections.Keywords
This publication has 19 references indexed in Scilit:
- Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative ColitisJournal of the American College of Surgeons, 2007
- Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative ColitisClinical Gastroenterology and Hepatology, 2006
- Low‐dose oral microemulsion ciclosporin for severe, refractory ulcerative colitisAlimentary Pharmacology & Therapeutics, 2005
- Ciclosporin use in acute ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 2005
- Predicting outcome in severe ulcerative colitis.Gut, 1996
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994
- FURTHER EXPERIENCE IN THE TREATMENT OF SEVERE ATTACKS OF ULCERATIVE COLITISThe Lancet, 1978
- The course and prognosis of ulcerative colitis: Part I Short-term prognosisGut, 1963
- Out-patient Treatment of Ulcerative ColitisBMJ, 1962
- Cortisone in Ulcerative ColitisBMJ, 1955